APA

Bousquet J., Cabrera P., Berkman N., Buhl R., Holgate S., Wenzel S., Fox H., Hedgecock S., Blogg M. & Cioppa G. D. (20050620). The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. : Allergy.

Chicago

Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M and Cioppa G Della. 20050620. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. : Allergy.

Harvard

Bousquet J., Cabrera P., Berkman N., Buhl R., Holgate S., Wenzel S., Fox H., Hedgecock S., Blogg M. and Cioppa G. D. (20050620). The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. : Allergy.

MLA

Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M and Cioppa G Della. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. : Allergy. 20050620.